1,000
Participants
Start Date
October 2, 2019
Primary Completion Date
July 17, 2021
Study Completion Date
October 22, 2021
Oxygen group
The control group will receive oxygen (first randomization), HFNO oxygen or standard oxygen (second randomization)
NIV Group
The experimental group will receive NIV (first randomization) alternated with HFNO or standard oxygen (second randomization)
Centre Hospitalier Universitaire Saint Eloi, Montpellier
University Hospital, Montpellier
OTHER